<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">93871</article-id><article-id pub-id-type="doi">10.7554/eLife.93871</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.93871.4</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Heparan sulfate-dependent phase separation of CCL5 and its chemotactic activity</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-331573"><name><surname>Yu</surname><given-names>Xiaolin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-331574"><name><surname>Duan</surname><given-names>Guangfei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331575"><name><surname>Pei</surname><given-names>Pengfei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331576"><name><surname>Chen</surname><given-names>Long</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331577"><name><surname>Gu</surname><given-names>Renji</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331578"><name><surname>Hu</surname><given-names>Wenrui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331579"><name><surname>Zhang</surname><given-names>Hongli</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331580"><name><surname>Wang</surname><given-names>Yan-Dong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331581"><name><surname>Gong</surname><given-names>Lili</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331582"><name><surname>Liu</surname><given-names>Lihong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-331583"><name><surname>Chu</surname><given-names>Ting-Ting</given-names></name><email>tingtingchu@szbl.ac.cn</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-180717"><name><surname>Li</surname><given-names>Jin-Ping</given-names></name><email>jin-ping.li@imbim.uu.se</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-331565"><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4880-5962</contrib-id><email>luosz@mail.buct.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00df5yc52</institution-id><institution>State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/037cjxp13</institution-id><institution>Institute of Medical Science, China-Japan Friendship Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00sdcjz77</institution-id><institution>Greater Bay Biomedical InnoCenter, Shenzhen Bay Laboratory</institution></institution-wrap><addr-line><named-content content-type="city">Shenzhen</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00df5yc52</institution-id><institution>Beijing Advanced Innovation Centre for Soft Matter Science and Engineering, Beijing University of Chemical Technology</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048a87296</institution-id><institution>Department of Medical Biochemistry and Microbiology, University of Uppsala</institution></institution-wrap><addr-line><named-content content-type="city">Uppsala</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0176yjw32</institution-id><institution>Universidade Federal de Minas Gerais</institution></institution-wrap><country>Brazil</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>01</day><month>07</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP93871</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-11-09"><day>09</day><month>11</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-11-16"><day>16</day><month>11</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.11.15.567182"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-04"><day>04</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.93871.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-05-16"><day>16</day><month>05</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.93871.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-06-19"><day>19</day><month>06</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.93871.3"/></event></pub-history><permissions><copyright-statement>© 2024, Yu, Duan et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Yu, Duan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-93871-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-93871-figures-v1.pdf"/><abstract><p>Secreted chemokines form concentration gradients in target tissues to control migratory directions and patterns of immune cells in response to inflammatory stimulation; however, how the gradients are formed is much debated. Heparan sulfate (HS) binds to chemokines and modulates their activities. In this study, we investigated the roles of HS in the gradient formation and chemoattractant activity of CCL5 that is known to bind to HS. CCL5 and heparin underwent liquid–liquid phase separation and formed gradient, which was confirmed using CCL5 immobilized on heparin-beads. The biological implication of HS in CCL5 gradient formation was established in CHO-K1 (wild-type) and CHO-677 (lacking HS) cells by Transwell assay. The effect of HS on CCL5 chemoattractant activity was further proved by Transwell assay of human peripheral blood cells. Finally, peritoneal injection of the chemokines into mice showed reduced recruitment of inflammatory cells either by mutant CCL5 (lacking heparin-binding sequence) or by addition of heparin to wild-type CCL5. Our experimental data propose that co-phase separation of CCL5 with HS establishes a specific chemokine concentration gradient to trigger directional cell migration. The results warrant further investigation on other heparin-binding chemokines and allows for a more elaborate insight into disease process and new treatment strategies.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>phase separation</kwd><kwd>chemotaxis</kwd><kwd>diffusion</kwd><kwd>gradient</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key R&amp;D Program of China</institution></institution-wrap></funding-source><award-id>2021YFC2103900</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>22261132513</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>22277009</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>22077010</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Joint Project of BRC-BC (Biomedical Translational Engineering Research Center of BUCT-CJFH)</institution></institution-wrap></funding-source><award-id>XK2023-14</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Joint Project of BRC-BC (Biomedical Translational Engineering Research Center of BUCT-CJFH)</institution></institution-wrap></funding-source><award-id>XK2022-07</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Swedish Research Council</institution></institution-wrap></funding-source><award-id>2021-01094</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Jin-Ping</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010031</institution-id><institution>China Postdoctoral Research Foundation</institution></institution-wrap></funding-source><award-id>Postdoctoral Fellowship Program GZC20230211</award-id><principal-award-recipient><name><surname>Pei</surname><given-names>Pengfei</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A biochemical approach shows co-phase separation of CCL5 with heparan sulfate establishes a specific chemokine concentration gradient for chemotactic activity.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Gradients of signaling molecules are ubiquitous in embryonic development and cellular activities, modulating cell migration, proliferation, and survival (<xref ref-type="bibr" rid="bib7">Griffith et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">Yamamoto et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Yu et al., 2009</xref>). Chemokines, belonging to a ∼45-member family of small (8–12 kDa) proteins, are signaling molecules that can induce distinct cellular chemotaxis in response to inflammatory stimuli in a concentration-dependent gradient (<xref ref-type="bibr" rid="bib34">Weber et al., 2013</xref>). Chemokines play critical roles in regulating cell migration in a wide range of biological activities, for example, developmental, homeostatic, and inflammatory/pathological processes (<xref ref-type="bibr" rid="bib5">Dyer et al., 2016</xref>). It is established that chemokines are secreted from source cells and immobilized on glycosaminoglycans (GAGs) including heparan sulfate (HS) in the extracellular matrix (<xref ref-type="bibr" rid="bib24">Proudfoot et al., 2003</xref>). The interaction of GAG–chemokine forms an immobilized gradient to provide direction to cell movement (<xref ref-type="bibr" rid="bib25">Proudfoot et al., 2017</xref>). Understanding how these chemokine gradients are formed and maintained is fundamental to identifying how they direct cell migration and proliferation. Straightforward molecular diffusion is often proposed as a possible mechanism (<xref ref-type="bibr" rid="bib11">Kicheva et al., 2007</xref>; <xref ref-type="bibr" rid="bib29">Schier and Needleman, 2009</xref>; <xref ref-type="bibr" rid="bib39">Yu et al., 2009</xref>). However, it is assumed that more complicated mechanisms are involved, which remains to be elucidated.</p><p>CCL5 (also known as RANTES, for ‘<underline>r</underline>egulated on <underline>a</underline>ctivation <underline>n</underline>ormal <underline>T</underline> cell <underline>e</underline>xpressed and <underline>s</underline>ecreted’) (<xref ref-type="bibr" rid="bib26">Roscic-Mrkic et al., 2003</xref>) is an inflammatory chemokine that recruits a wide variety of leukocytes, including monocytes, granulocytes, and T cells, as well as mast cells and dendritic cells, through chemokine gradients (<xref ref-type="bibr" rid="bib27">Roy et al., 2015</xref>; <xref ref-type="bibr" rid="bib34">Weber et al., 2013</xref>). CCL5 is composed 68 amino acids that reversibly self-assembles into high-MW oligomers, up to &gt;600 kDa. This highly basic protein binds heparin with high affinity (<xref ref-type="bibr" rid="bib17">Mulloy, 2005</xref>) and the oligomerization of CCL5 for the formation of gradient is modulated by GAGs on cell surface (<xref ref-type="bibr" rid="bib24">Proudfoot et al., 2003</xref>).</p><p>Liquid–liquid phase separation (LLPS) driven by weak interactions between multivalent biomolecules was shown to be an important mechanism by which mesoscale structures of the condensates can form within the cell (<xref ref-type="bibr" rid="bib36">Xue et al., 2019</xref>) and on the cell surface (<xref ref-type="bibr" rid="bib37">Xue et al., 2022</xref>). Within phase-separated condensates, biomolecules are often mobile and interchanged between the dense and light phases. Based on reported information and our previous study, we have studied the implications of HS on CCL5 gradient formation and its chemotactic activity. Both in vitro and in vivo experiments demonstrate that co-phase separation of CCL5 with HS establishes specific chemokine concentration gradients for chemotactic activity.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Co-phase separation of CCL5 and heparin</title><p>To illustrate the phase separation property of CCL5 in liquid, recombinant protein expressed in <italic>E. coli</italic> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib21">Proudfoot et al., 1996</xref>) was labeled with organic dye Cy3 (CCL5-Cy3) and mixed with heparin at different ratios. After 30-min formation of droplets was examined by fluorescence under confocal microscopy. At the ratio of 20:1 CCL5-Cy3 to heparin, few tiny droplets were detected, indicating phase separation. With increased ratio of CCL5-Cy3:heparin to 1:20 (20 μM CCL5-Cy3:1 μM heparin), large and round droplets were formed (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>). Further increases in heparin concentration (ratio 1:50) prevented droplet formation as a ‘reentrant’ behavior. Since heparin is a linear repetitive structure with rich negative charges, the LLPS seems following a similar mechanism as RNA in the phase separation of many RNA-binding proteins (<xref ref-type="bibr" rid="bib6">Ghosh et al., 2019</xref>). Longer incubation revealed that the droplets were dynamic and some became fused to form larger droplets (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) that displayed a quick recovery speed in the fluorescence recovery after photobleaching (FRAP) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The heparin-induced phase separation of CCL5 was attenuated at high salt concentrations as illustrated by incubation at different KCl concentrations in KMEI buffer (0.5M KCl, 0.1M imidazole , 10mM EDTA, 20mM MgCl2, KMEI; pH 7.1) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A, B</xref>). In comparison, a mutant (A22K-CCL5) with higher positive charge density showed stronger interaction with heparin (<xref ref-type="bibr" rid="bib1">Brandner et al., 2009</xref>) and formed aggregates instead of phase separation with heparin in KMEI buffer (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C, D</xref>). These results indicated that heparin-induced LLPS of CCL5 was based on weak electrostatic interactions between the negatively charged polysaccharide and the basic protein of CCL5, while strong ionic interaction has abolished this effect.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>CCL5 phase separates with heparin in solution.</title><p>(<bold>A</bold>) Confocal images of assembling status of 20 μM CCL5-Cy3 mixed with heparin at different ratios and 5% PEG (Polyethylene Glycol). Scale bar = 10 μm. (<bold>B</bold>) Turbidity changes with increase of heparin concentration were measured at 620 nm. (<bold>C</bold>) Fusion of phase-separated droplets formed at the ratio of CCL5-Cy3:heparin = 1:2. The white arrows indicate the dynamic fusion of two adjacent droplets. (<bold>D</bold>) Representative fluorescence recovery after photobleaching (FRAP) results of droplets formed by CCL5-Cy3:heparin = 1:2 depicted in <bold>A</bold>, showing the intensity of fluorescence pre- and after photobleachin. The images of representative droplets in different recovery stages are shown. (<bold>E</bold>) Confocal images of assembling status of <sup>44</sup>AANA<sup>47</sup>-CCL5 or CCL5 in the presence of heparin. Scale bar = 10 μm. (<bold>F</bold>) Comparison of CCL5 and <sup>44</sup>AANA<sup>47</sup>-CCL5 turbidity in the presence of heparin. Data are mean ± standard deviation (s.d.). <italic>n</italic> = 3 (for <bold>B, F</bold>). Normal distribution was assessed by the Shapiro–Wilk (SW) normality test. p values were determined by unpaired two-tailed <italic>t</italic>-tests.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Excel file containing the results of turbidity and descriptive statistics in <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Excel file containing relative fluorescent value in <xref ref-type="fig" rid="fig1">Figure 1D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Excel file containing the results of turbidity and descriptive statistics in <xref ref-type="fig" rid="fig1">Figure 1F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig1-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Protein expression and purification.</title><p>Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) showed the molecular weight and purity of CCL5 (<bold>A</bold>) and CCL5-EGFP (<bold>B</bold>).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Original file for the sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig1-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Image containing <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref> and original scans of the sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) with sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig1-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Original file for the sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig1-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata4"><label>Figure 1—figure supplement 1—source data 4.</label><caption><title>Image containing <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref> and original scans of the sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) with sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig1-figsupp1-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>The effect of salt concentration on phase separation.</title><p>(<bold>A</bold>) Confocal images of assembling status of 20 μM CCL5-Cy3 mixed with heparin with increasing salt concentration. Scale bar = 10 μm. (<bold>B</bold>) Turbidity changes with different increasing salt concentrations. (<bold>C</bold>) Confocal images of assembling status of A22K-CCL5 or CCL5 in the presence of heparin. Scale bar = 10 μm. (<bold>D</bold>) Fluorescence recovery after photobleaching (FRAP) of the aggregates formed by A22K-CCL5-Cy3, showing the intensity of fluorescence pre- and after photobleaching.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Comparison of binding of CCL5 and <sup>44</sup>AANA<sup>47</sup>-CCL5 to heparin tetrasaccharide.</title><p>(<bold>A</bold>) Binding mode of heparin tetrasaccharide to <sup>44</sup>AANA<sup>47</sup>-CCL5 or CCL5 shown by molecular docking. On the right are the details framed by the dotted line. (<bold>B</bold>) Comparison of binding free energy of different interacting forces between CCL5/<sup>44</sup>AANA<sup>47</sup>-CCL5 and heparin tetrasaccharide. The mutation led to change in electrostatic interaction forces.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig1-figsupp3-v1.tif"/></fig></fig-group><p>An earlier study showed complex formation of CCL5 with a heparin disaccharide, which proposed the BBXB motif of CCL5 playing essential role in the interaction between the chemokine and the disaccharide (<xref ref-type="bibr" rid="bib30">Shaw et al., 2004</xref>). In light with this finding, we mutated <sup>44</sup>RKNR<sup>47</sup>, a conserved positively charged BBXB motif of CCL5, to hydrophobic alanine motif <sup>44</sup>AANA<sup>47</sup> (<xref ref-type="bibr" rid="bib23">Proudfoot et al., 2001</xref>), which is expected to reduce the interaction with heparin. As anticipated, the phase separation of the mutant <sup>44</sup>AANA<sup>47</sup>-CCL5 in solution containing heparin formed much smaller and fewer droplets in comparison to WT CCL5 (<xref ref-type="fig" rid="fig1">Figure 1E, F</xref>). The electrostatic interaction feature was further demonstrated by molecular docking analysis using a tetrasaccharide structure of heparin (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). The results showed the docking of heparin tetrasaccharide into human CCL5, forming crucial electrostatic contacts at the CCL5 dimer interface, where it packed tightly against Arg 44, Lys45, and Arg47 (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). In comparison, binding free energy of heparin to the <sup>44</sup>AANA<sup>47</sup>-CCL5 mutant was significantly higher (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>).</p></sec><sec id="s2-2"><title>Heparin-dependent phase separation is one essential step for CCL5 gradient formation</title><p>To elucidate the intrinsic connection between the heparin-dependent phase separation of CCL5 and its chemotactic activity, we developed an in vitro diffusion assay in which purified His-CCL5-EGFP (400 ng/μl) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) was immobilized on heparin-beads or on Ni-NTA-beads. In 96-well plates, the beads were embedded in the center of Matrigel (<xref ref-type="bibr" rid="bib15">Makarenkova et al., 2009</xref>) and incubated for 12 hr. Diffusion of the His-CCL5-EGFP was monitored by measuring fluorescence intensity along a line interval passing through the bead localized center. As shown in <xref ref-type="fig" rid="fig2">Figure 2A</xref>, His-CCL5-EGFP diffused a considerable distance away from the heparin-beads, forming a long and shallow gradient, whereas His-CCL5-EGFP did not diffuse from the Ni-NTA beads (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). In comparison, <sup>44</sup>AANA<sup>47</sup>-CCL5 binding to the heparin-beads was significantly weaker and did not diffuse (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, right panel). To exclude the potential effect of EGFP, we repeated the experiment using Cy3-tagged CCL5. In a similar manner, the heparin-beads bound CCL5-Cy3 diffused in Matrigel but not the Ni-NTA beads bound CCL5-Cy3 as revealed by three-dimensional (3D) imaging (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). These results suggest that heparin-beads tethered CCL5 via phase separation, which enables rapid exchange with the external environment leading to diffusion and gradient formation; while the Ni-NTA beads bound CCL5 lacks phase separation, therefore no diffusion.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Co-phase separation of CCL5 and heparin establishes chemokine gradient.</title><p>(<bold>A</bold>) CCL5-EGFP or <sup>44</sup>AANA<sup>47</sup>-CCL5-EGFP were bound to heparin-beads or Ni-NTA beads, respectively, and were placed in Matrigel in 96-well plate. After incubation for 12 hr images were taken to quantify the fluorescence intensity. (<bold>B</bold>) Quantification of the fluorescence signals along the lines with arrows indicated in <bold>A</bold>. (<bold>C</bold>) Illustration of in vitro chemotaxis assay. (<bold>D</bold>) Heparin-beads or Ni-NTA beads bound with CCL5 or <sup>44</sup>AANA<sup>47</sup>-CCL5 were placed in the lower chamber. THP-1 cells (3 × 10<sup>5</sup> cells) were added to upper chamber. After 4 hr, THP-1 in the lower chamber was collected and counte. Data are mean ± standard deviation (s.d.). <italic>n</italic> = 3. Normal distribution was assessed by the Shapiro–Wilk (SW) normality test. p values were determined by unpaired two-tailed <italic>t</italic>-tests.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Excel file containing output results of gray value in <xref ref-type="fig" rid="fig2">Figure 2B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Excel file containing the results of cell counting and descriptive statistics in <xref ref-type="fig" rid="fig2">Figure 2D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Chemotactic function of CCL5-EGFP.</title><p>Labeled CCL5 has similar activity as CCL5, 50 nM CCL5, CCL5-EGFP, or CCL5-Cy3 were added to the lower chamber of the Transwell. THP-1 cells were added to upper chambers. Data are mean ± standard deviation (s.d.). <italic>n</italic> = 3. p values were determined by unpaired two-tailed <italic>t</italic>-tests. NS, not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Diffusion of the CCL5-Cy3 in heparin-beads or Ni-NTA beads.</title><p>Beads bound with CCL5-Cy3 placed in Matrigel were imaged and reconstructed by Leica DMi8.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig2-figsupp2-v1.tif"/></fig></fig-group><p>Next, to test whether the formed chemokine gradients of CCL5-heparin-beads contribute to the chemotactic activity, we established an in vitro chemotaxis assay using Transwell (<xref ref-type="bibr" rid="bib24">Proudfoot et al., 2003</xref>) in which CCL5 either in heparin-beads or in Ni-beads were placed in the lower chamber (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) and THP-1 cells were placed in the upper chamber. Again, CCL5-heparin-beads showed robustly higher chemotactic activity (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), while CCL5-Ni-NTA beads essentially did not induce chemotaxis. In comparison, <sup>44</sup>AANA<sup>47</sup>-CCL5-heparin-beads showed relatively weaker chemotactic activity than WT-CCL5-heparin-beads (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The dramatic difference in the chemotactic activity of CCL5 between immobilization on heparin-beads or Ni-NTA beads indicates that the chemotactic function is achieved by establishment of a functional gradient rather than just immobilization.</p></sec><sec id="s2-3"><title>HS-dependent CCL5 phase separation and its chemotactic activity</title><p>Having seen the functional roles of heparin in CCL5 gradient formation in solution and Matrigel, we wanted to find out whether HS on the cell surface also can phase separate with CCL5 using a pair of well-established cell lines, CHO-K1 (wild-type) and CHO-677 (mutant lacking HS). Co-incubation of CCL5-Cy3 with the cells resulted in strong signals on the cell surface of CHO-K1 revealed by confocal microscopy, indicating formation of puncta surrounding the cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). However, CHO-677 completely lacked the signals. The finding was further verified by Z-stack scanning (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Fluorescence recovery of about 40% condensates after photobleaching (FRAP) indicates there is a liquidity of the condensates on CHO-K1 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). These results indicated that CCL5 formed phase separation with HS on the CHO K1 cell surface, which was not possible in CHO-677 cells lacking HS.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>CCL5 phase separates with heparan sulfate on the cell surface.</title><p>(<bold>A</bold>) Microscopy images of CCL5-Cy3 on the surface CHO-K1 and CHO-677 as well as CHO-K1 treated with 1 mg/ml heparin. From left to right, the images are fluorescent-field, bright-field, and overlay of two illuminations. Scale bar = 10 μm. (<bold>B</bold>) Z-stack scanning of CCL5-Cy3 phase separation on CHO-K1 cell surface. The cell was imaged by confocal microscope with the Z-stack method. Scale bar = 10 μm. (<bold>C</bold>) Fluorescence recovery after photobleaching (FRAP) of the condensates formed by CCL5-Cy3, showing the intensity of fluorescence pre- and after photobleaching. The size of the representative droplets in different recovery stages are shown above of the graph. (<bold>D</bold>) Graphical illustration of the cell-based chemotaxis assay. CHO cells (1 × 10<sup>5</sup> cells/well) were plated onto the lower chamber for 24 hr (fully attached) and CCL5 or <sup>44</sup>AANA<sup>47</sup>-CCL5 or heparin were added as indicated. THP-1 cells (3 × 10<sup>5</sup>) were placed on upper chambers. After 4 hr, a small volume of medium in the lower chamber was aspirated to count THP-1 transmigrated through the membrane. (<bold>E</bold>) Quantification of THP-1 collected from the lower chambe. Data are mean ± standard deviation (s.d.). <italic>n</italic> = 3. Normal distribution was assessed by the Shapiro–Wilk (SW) normality test. p values were determined by unpaired two-tailed <italic>t</italic>-tests.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Excel file containing relative fluorescent value in <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Excel file containing the results of cell counting and descriptive statistics in <xref ref-type="fig" rid="fig3">Figure 3E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig3-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><sup>44</sup>AANA<sup>47</sup>-CCL5 did not immobilize to the surface of CHO-K1.</title><p>CHO-K1 were treated with 500 nM <sup>44</sup>AANA<sup>47</sup>-CCL5. From left to right, the pictures showed bright-field, fluorescent-field, and overlay of two illuminations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig3-figsupp1-v1.tif"/></fig></fig-group><p>In order to know whether the HS-dependent CCL5 phase separation is essential for the chemotactic activity of CCL5, we established a cell-based chemotaxis assay (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). CHO-K1 cells along with CCL5 was placed in the lower chamber for 1 hr and THP-1 cells was seeded in the upper chamber, separated by a porous membrane. After incubation for 4 hr, THP-1 cells transmigrated into the lower chamber was quantified. The results revealed that both CCL5 alone and CHO-K1 alone had low chemotactic activity; in contrast, CHO-K1 in the presence of CCL5 showed significantly higher chemotactic activity (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). In the same line, the chemotactic activity of CCL5 was much lower when incubated with CHO-677 in the lower chamber. As it was found that higher proportion of heparin reduced phase separation of CCL5 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), we tested whether this is the case in cells. Indeed, addition of heparin in the incubation of CHO-K1 abolished the phase separation of CCL5-Cy3 on the cells surface (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, lower panel), accordingly attenuated the chemotactic activity of CCL5 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). When <sup>44</sup>AANA<sup>47</sup>-CCL5 was incubated with CHO-K1 cell, no obvious phase-separated condensates appeared on the cell surface (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), and consequently, <sup>44</sup>AANA<sup>47</sup>-CCL5 showed reduced chemotactic activity when incubated with CHO-K1 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) in comparison with WT CCL5. Thus, we may conclude that HS is essential on the CHO cell surface for phase separation of CCL5 and its chemotaxis function.</p><p>Based on the observation that CCL5 forms a concentration gradient on heparin-beads where heparin-driven phase separation enabled CCL5 diffuse, we hypothesized a similar scenario of HS on cells, for example, CCL5 was immobilized or condensed by HS on the cell surface through phase separation, and gradually diffuse to form a gradient to guide cell migration. To test this conjecture, we transfected the construct of CCL5-EGFP into CHO-K1. The cells were co-cultured with human umbilical vein endothelial cells (HUVECs) (<xref ref-type="bibr" rid="bib20">Øynebråten et al., 2015</xref>). Released CCL5-EGFP from CHO-K1 cells was readily taken up by nearby HUVEC cells, formed bright phase-separated condensates on the cell surface (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). With extended incubation, the condensates became fused (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), in a similar way of CCL5-heparin condensates in solution (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The FRAP experiment showed reasonable FRAP, indicating liquid-like properties of the condensates on the cell surface (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). To further illustrate the gradient formation of the CCL5-EGFP condensates, we cultured HUVEC in Matrigel and embedded tiny amounts (about 400 cells) of the CCL5-EGFP transfected CHO-K1 as a source of CCL5-EGFP. Confocal microscopy monitoring found decreased concentration of CCL5-EGFP with increasing distance of HUVEC from the source cells (CCL5-EGFP expressing CHO), confirming that CCL5-EGFP established a gradient by phase separation on its target cells (<xref ref-type="fig" rid="fig4">Figure 4D, E</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B, C</xref>). Further, both CHO-K1 and CHO-677 transfected with CCL5-EGFP were analyzed on the same setting. The results show that a gradient was formed in CHO-K1 cells when co-cultured with CCL5-EGFP transfected CHO-K1 in Matrigel, while CHO-677 failed to form the concentration gradient (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Furthermore, the chemotactic activity was demonstrated by placing CCL5-EGFP transfected CHO-K1 in a lower chamber and THP-1 in the upper chamber. Counting the transmigrated THP-1 cells showed that the transfected CHO-K1 had stronger chemotactic activity compared with WT-CHO-K1 (<xref ref-type="fig" rid="fig4">Figure 4F</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Formation of chemokine gradient on the cell surface by phase separation.</title><p>(<bold>A</bold>) Human umbilical vein endothelial cells (HUVECs) were seeded on the plates for 24 hr and stained with Dil (Cell membrane red fluorescent probe). After washing with PBS (Phosphate buffer saline), CCL5-EGFP transfected CHO-K1 were added and co-cultured for 24 hr before taking the images (scale bar = 10 μm). (<bold>B</bold>) Fusion events of droplets formed by CCL5-EGFP on HUVEC cell surface. The white arrows in cropped images indicate the fusion of two droplets with time. (<bold>C</bold>) Fluorescence recovery after photobleaching (FRAP) of the condensates formed by CCL5-EGFP in HUVEC cell surface, showing the intensity of fluorescence pre- and after photobleaching. The images of representative droplets in different recovery stages are shown. (<bold>D</bold>) HUVEC cells were seeded on the plate and firmly adhered before adding the 400 CCL5-EGFP transfected CHO-K1 cells placed in 50% of Matrigel. After 1-hr co-culture, confocal images were taking showing CCL5-EGFP diffusion on the surface of HUVEC. Dotted white circle indicates the source cell of CCL5-EGFP transfected CHO-K1. Scale bar = 100 μm. (<bold>E</bold>) Quantification of the fluorescence intensity shows decreased signals of CCL5-EGFP as the distance from the source cells increased. (<bold>F</bold>) The chemotaxis assay (same experimental conditions as described in <xref ref-type="fig" rid="fig1">Figure 1</xref>) shows higher activity of CCL5-EGFP transfected CHO-K1 cells than wild-type CHO-K1 cell. Data are mean ± standard deviation (s.d.). <italic>n</italic> = 3. Normal distribution was assessed by the Shapiro–Wilk (SW) normality test. p values were determined by unpaired two-tailed <italic>t</italic>-tests.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Excel file containing relative fluorescent value in <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig4-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Excel file containing output results of gray value and normalized concentration in <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig4-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Excel file containing the results of cell counting and descriptive statistics in <xref ref-type="fig" rid="fig4">Figure 4F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig4-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Diffusion of CCL5-EGFP on the cell surface.</title><p>(<bold>A</bold>) Confocal images of transfected CHO-K1 and human umbilical vein endothelial cells (HUVECs). Scale bar = 100 μm. The yellow boxes are shown in higher magnification on the right. Scale bar = 10 μm. CCL5-EGFP was expressed by transfected CHO-K1 and then adhere to the surface of HUVEC and formed phase separation. (<bold>B</bold>) The range of CCL5-EGFP diffusion on HUVEC cell surface at different time. The black dashed box showed the final image size. (<bold>C</bold>) Fluorescence intensity along the dotted lines indicated in <bold>B</bold>. (<bold>D</bold>) Confocal images of transfected CHO-K1 and CHO-K1 or CHO-677. CCL5-EGFP was expressed by transfected CHO-K1 and then adhere to the surface of CHO-K1 and formed phase separation but CHO-677 completely lack the signals. Scale bar = 25 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Ex vivo and in vivo demonstration of HS-dependent chemotactic activity of CCL5</title><p>To further verify our findings, we placed HUVEC or CHO cells in the lower chamber in the presence of CCL5 and blood cells that lysed red cells in the upper chamber of the Transwell device to detect transmigration of the inflammatory cells. Quantification of the transmigrated cells into the lower chamber after incubation for 4 hr revealed that neither CCL5 alone nor CHO-677 in the presence of CCL5 showed substantial chemotactic activity; in contrast, HUVEC and CHO-K1 in the presence of CCL5 showed significantly higher chemotactic activity. It should be pointed out that the total blood cells that lysed red cells in the three blood samples varied dramatically, resulting in the great deviations in the number of transmigrated cells of each sample. Nevertheless, the trend of chemotactic activity under the different conditions is consistent in all samples (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Transmigration of blood cells that lysed red cells.</title><p>The cells (CHO-K1, CHO-677, or human umbilical vein endothelial cell [HUVEC]) (1 × 10<sup>5</sup> cells/well) as indicated were plated onto the lower chamber for 24 hr (fully attached) and CCL5 was added for 1 hr. The blood cells that lysed red cells isolated from three healthy volunteer donors were placed in the upper chamber (total number of cells: Sample 1: 8.65 × 10<sup>5</sup>; Sample 2: 2.31 × 10<sup>6</sup>; Sample 3: 2.23 × 10<sup>6</sup>). After culturing for 4 hr, the total transmigrated cells in the lower chamber were counted.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Excel file containing the results of cell counting in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig5-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig5-v1.tif"/></fig><p>To verify our findings in vivo, wild-type, or mutant CCL5 was injected into the peritoneal cavity of Balb/c mice and peritoneal cells recruitment was monitored (<xref ref-type="bibr" rid="bib24">Proudfoot et al., 2003</xref>). Wild-type CCL5 induced a robust increase of total cells in the peritoneal lavage to a level approximately fourfold over the saline control (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In comparison, though <sup>44</sup>AANA<sup>47</sup>-CCL5 group had a higher cell number than saline control, the recruited cells were much less than CCL5. Heparin (1 mg/ml) co-injected with wild-type CCL5 attenuated the recruitment of inflammatory cells, which, again, can be ascribed to the competitive interaction with endogenous HS in binding to CCL5. Overall, these results demonstrate that the phase separation of CCL5 with HS indeed contribute to chemotaxis function of CCL5 in vivo.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Chemokines phase separation promotes cell recruitment in vivo.</title><p>Mice were treated by intraperitoneal injection of CCL5 or the reagents as indicated. After 18 hr, the animals were sacrificed and peritoneal lavage was collected. Total cell number was counted by automated cell counter. Data are mean ± standard deviation (s.d.). <italic>n</italic> = 4. Normal distribution was assessed by the Shapiro–Wilk (SW) normality test. p values were determined by unpaired two-tailed <italic>t</italic>-tests.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Excel file containing the results of cell counting and descriptive statistics in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-93871-fig6-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig6-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>It has been suggested that an important component of the chemokine signaling is formation of a haptotactic gradient through immobilization of chemokines on cell surface GAGs (<xref ref-type="bibr" rid="bib15">Makarenkova et al., 2009</xref>). Interactions with GAGs facilitate gradient formation of chemokine, providing directional cues for migrating cells. HS is one member of the GAGs family and ubiquitously expressed on the cells surface of endothelial and epithelial cells, forming glycocalyx (<xref ref-type="bibr" rid="bib32">Simon Davis and Parish, 2013</xref>). It is known that HS (and its analog heparin) binds to a broad spectrum of cytokines, functioning as a co-receptor to mediate signaling activity of the cytokines (<xref ref-type="bibr" rid="bib35">Xie and Li, 2019</xref>). Several inflammatory chemokines, including CCL5, bind to HS/heparin (<xref ref-type="bibr" rid="bib24">Proudfoot et al., 2003</xref>); however, the molecular mechanisms of HS in CCL5-induced chemotactic activity have not been reported.</p><p>Phase separation is a common mechanism for protein assembly and compartmentalization, and it contributes to a variety of cellular processes, including the formation of membraneless organelles, signaling complexes, the cytoskeleton, and numerous other supramolecular assemblies (<xref ref-type="bibr" rid="bib10">Hyman et al., 2014</xref>; <xref ref-type="bibr" rid="bib40">Zbinden et al., 2020</xref>). Emerging evidence indicates that biomolecules in phase-separated liquid droplets are mobile and transitorily interact with surrounding molecules (<xref ref-type="bibr" rid="bib18">Nakashima et al., 2019</xref>). Most of CC chemokines are found to occur oligomerization in vivo<italic>,</italic> which may be modulated by GAGs (<xref ref-type="bibr" rid="bib8">Hoogewerf et al., 1997</xref>). However, the exceptional species of CCL7 is present at monomer, and has multiple GAG-binding epitopes, enabling it to functions as a non-oligomerizing chemokine (<xref ref-type="bibr" rid="bib28">Salanga et al., 2014</xref>). In comparison, CXCL4 (Platelet Factor 4) binds strongly to heparin (<xref ref-type="bibr" rid="bib31">Shi et al., 2023</xref>) and HS (<xref ref-type="bibr" rid="bib9">Horton et al., 2021</xref>), leading to formation of oligomers and aggregates. It should be interesting to examine whether these chemokines also undergo phase separation and to find out whether LLPS is controlled by oligomerization.</p><p>Earlier study reported that the conserved and positively charged BBXB motif in the CC chemokines is the key to interact with negatively charged GAGs through multivalent weak ionic interactions (<xref ref-type="bibr" rid="bib12">Liang et al., 2016</xref>). Structural study revealed that the basic amino acids R44, K45, and R47 create two positively charged regions on the interface of CCL5 dimer, facilitating the interaction with heparin (<xref ref-type="bibr" rid="bib14">Lortat-Jacob et al., 2002</xref>). Based on above findings, using our established LLPS method, we demonstrated that CCL5 phases separate on the cell surface via an HS-dependent mechanism, which is required for CCL5 chemotaxis. Mutations on the basic amino acids R44, K45, and R47 resulted in loosing binding of CCL5 to heparin-beads, accordingly, lost its chemotactic activity. This finding also supports the fact that the phase separation of CCL5 with HS is mediated by weak electrostatic interactions, which facilitates the diffusion of CCL5 in solution to form a gradient.</p><p>It is well established that HS constitutes the major component of the glycocalyx on the endothelial cell surface (<xref ref-type="bibr" rid="bib19">Oshima et al., 2021</xref>), and our earlier results showed that degradation of endothelial surface HS by heparanase impaired the function of MIP-2/CXCL2-induced leukocyte rolling, adhesion, and transmigration (<xref ref-type="bibr" rid="bib16">Massena et al., 2010</xref>). From the finding of this study that the ratio of CCL5:heparin modulated droplets and condensates formation (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>), we may assume that HS on the cell surface should have a sufficient capacity to interact with chemokines, controlling their chemotactic activity and inflammatory cell migration. This assumption is supported by the finding that overexpressing CCL5 in CHO-K1 cells led to higher chemotactic activity, which may represent a scenario of acute inflammatory reaction.</p><p>Collectively, our studies provide the first evidence that CCL5 gradient formation and chemotactic activity are dependent on HS. The interaction between CCL5 and HS is through a weak multivalent electrostatic binding, which facilitates LLPS and diffusion of the chemokine (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Notably, the results suggest that there may exist a physiological balance between CCL5 and HS, modulating the chemokine activity. This finding supports the hypothesis to develop chemokine-binding HS mimetics that may competitively interfere with the HS–chemokine binding and phase separation, accordingly modulating inflammatory reactions.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Schematic model of CCL5 phases separation along with heparan sulfate on the cell surface.</title><p>The inflammatory cells secrete chemokines that are immobilized by heparan sulfate in the form of liquid–liquid phase separation and subsequently diffused to form a concentration gradient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93871-fig7-v1.tif"/></fig></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">CCL5</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">HGNC:10632</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background<break/>(<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">Rosetta(DE3)</td><td align="left" valign="bottom">Biomed</td><td align="left" valign="bottom">BC204-01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background<break/>(<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">OrigamiB(DE3)</td><td align="left" valign="bottom">Biomed</td><td align="left" valign="bottom">BC205-01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><sup>44</sup>AANA<sup>47</sup>-CCL5-mut-F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib20">Øynebråten et al., 2015</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GCAGTCGTCTTTGTCACCGCGGCGAACGCGCAAGTGTGTGCCAACCCA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><sup>44</sup>AANA<sup>47</sup>-CCL5-mut-R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib20">Øynebråten et al., 2015</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TGGGTTGGCACACACTTGCGCGTTCGCCGCGGTGACAAAGACGACTGC</named-content></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET-28a</td><td align="left" valign="bottom">Miao Ling Plasmid</td><td align="left" valign="bottom">P51040</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cy3-NHS</td><td align="left" valign="bottom">ATT Bioquest</td><td align="char" char="." valign="bottom">1023</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Heparin</td><td align="left" valign="bottom">GlycoNovo</td><td align="left" valign="bottom">C-HEPPIM</td><td align="left" valign="bottom">Mw: 13.980 Da</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HUVEC</td><td align="left" valign="bottom">Pricella</td><td align="left" valign="bottom">CL-0675</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Cricetulus griseus</italic>)</td><td align="left" valign="bottom">CHO-K1</td><td align="left" valign="bottom">GlycoNovo</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Cricetulus griseus</italic>)</td><td align="left" valign="bottom">CHO-677</td><td align="left" valign="bottom">GlycoNovo</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">BALB/cAnNCrl</td><td align="left" valign="bottom">Vital River</td><td align="char" char="." valign="bottom">211</td><td align="left" valign="bottom">Female</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Human peripheral blood cell</td><td align="left" valign="bottom">China-Japan Friendship Hospital</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Freshly isolated from volunteers</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CHARMM-GUI</td><td align="left" valign="bottom">CHARMM-GUI</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_025037">SCR_025037</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GROMACS</td><td align="left" valign="bottom">GROMACS</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014565">SCR_014565</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">gmx_MMPBSA</td><td align="left" valign="bottom">GitHub</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002630">SCR_002630</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">LAS X software 3.5</td><td align="left" valign="bottom">Leica Application Suite X</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013673">SCR_013673</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Protein expression and purification</title><p>DNA sequences of wild-type human CCL5 (<xref ref-type="bibr" rid="bib4">Donlon et al., 1990</xref>) were synthesized by General Biosystems, China. For the mutant of CCL5 (<sup>44</sup>AANA<sup>47</sup>-CCL5), site-directed mutations were introduced using the Quikchange mutagenesis kit (Beyotime Biotechnology, China) using mutagenesis primes: 5′-<named-content content-type="sequence">GCAGTCGTCTTTGTCACCGCGGCGAACGCGCAAGTGTGTGCCAACCCA</named-content>-3′. CCL5 gene and <sup>44</sup>AANA<sup>47</sup>-CCL5 gene were constructed in pET-28a vector (Miao Ling Plasmid, China) and transformed into <italic>E. coli</italic> Rosetta (DE3) (Biomed, China) for expression (<xref ref-type="bibr" rid="bib21">Proudfoot et al., 1996</xref>; <xref ref-type="bibr" rid="bib22">Proudfoot and Borlat, 2000</xref>). The products contained an additional Met residue at the N-terminus (Met-CCL5) and His tag or EGFP-fusion protein. Bacterium were grown to optical density of 0.6 at 37°C and induced with 0.5 mM isopropyl-β-<sc>d</sc>-thiogalactopyranoside (IPTG) at 37°C for 5 hr. The cells were harvested by centrifugation (4000 rpm, 20 min at 4°C), resuspended in lysis buffer (25 mM Tris–HCl, 100 mM NaCl, pH 8.0) and disrupted by sonication. The cell lysate was centrifuged at 12,000 rpm for 35 min at 4°C. To recover the recombinant CCL5 and <sup>44</sup>AANA<sup>47</sup>-CCL5 proteins that were mainly distributed in the inclusion bodies, the pellet was collected and resuspended in denaturing buffer (100 mM Tris–HCl, 6 M guanidine–HCl, pH 8.0) and disrupted by sonication. Cell debris was removed by centrifugation (30,000 × <italic>g</italic>, 20 min at 4°C). The proteins in the supernatant were refolded by dialysis in to refolding buffer (0.9 M guanidine–HCl, 100 mM Tris–HCl, 5 mM methionine, 5 mM cysteine, pH 8.0). After repeated change of dialysis buster, the protein debris was removed by centrifugation (30,000 × <italic>g</italic>, 20 min at 4°C) and the supernatants were applied to His-Trap chelating column (GE Healthcare), washed by refolding buffer and eluted with the same buffer containing 30 mM imidazole. The purified proteins were dialyzed into 1.0% vol/vol acetic acid aqueous solution twice and finally into 0.1% vol/vol trifluoroacetic acid aqueous solution. The purity of the recombinant CCL5 was analyzed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis. After lyophilization, the CCL5 proteins were dissolved in water and stored in −80°C.</p><p>For a better folding, the CCL5-EGFP and <sup>44</sup>AANA<sup>47</sup>-CCL5-EGFP fusion proteins were expressed in <italic>E. coli</italic> OrigamiB(DE3) and induced by 0.5 mM IPTG at 25°C for 12 hr. The proteins were purified by the same procedure as above.</p></sec><sec id="s4-2"><title>Labeling of CCL5 with Cy3</title><p>Cy3 monosuccinimidyl ester (Cy3-NHS; ATT Bioquest, USA) was mixed with CCL5 to a final concentration of 1.5 mg/ml, pH 9 adjusted with 1 M NaHCO<sub>3</sub>. The mixture was incubated with shaking at 37°C for 1 hr, and then dialyzed in a 10-kDa dialysis tube (Thermo Fisher, USA) in ddH<sub>2</sub>O. These Cy3-labled CCL5 was mixed with un-labeled protein at 1:40–1:20 ratio. This dilution of the labeled protein is in consideration that N-terminus of CCL5 may be labeled with Cy3, which is known to affect the activity of the protein.</p></sec><sec id="s4-3"><title>Cell culture</title><p>HUVECs were cultured in Dulbecco’s modified Eagle’s medium 1× with glucose (4.5 g/l), 10% fetal bovine serum (FBS), and 1% antibiotics (penicillin/streptomycin). CHO-K1/CHO-677 cells were cultured in F12K medium containing 10% FBS and 1% antibiotics. THP-1 were cultured in RPMI1640 medium containing 10% FBS and 1% antibiotics. All cells were cultured at 37°C with 5% CO<sub>2</sub> in a humidified incubator.</p></sec><sec id="s4-4"><title>Phase separation of CCL5 on cell surface</title><p>Cells were plated onto an 8-well Lab-Tek chambered coverglass (Thermo Fisher, USA) to around 70% confluency. Before imaging, the medium was discarded, and the cells were washed with PBS twice. Then, the protein solution diluted in the culture medium (500 nM) was added to the cells and incubation 1 hr in a cell incubator. Confocal microscopy image was captured with an inverted Leica DMi8 microscope, equipped with lasers for 489 and 554 nm excitation. Images were acquired using a ×63 objective (oil immersion).</p></sec><sec id="s4-5"><title>Z-stack for living cell 3D rendering</title><p>3D reconstruction for living cells were implemented with an inverted Leica DMi8 microscope. Images were acquired using the ×63 oil immersion lens, a pinhole of 1 AU, 522 nm laser with 10% laser power, followed by setting the starting position and end position of Z-stack, 100–200 Nr. of Steps or 1 μm z-step size was selected.</p></sec><sec id="s4-6"><title>Imaging of CCL5 phase separation in vitro</title><p>CCL5 were diluted to 4–6 mg/ml in KMEI buffer (150  mM KCl, 1  mM MgCl<sub>2</sub>, 1  mM Ethylenebis (oxyethylenenitrilo) tetraacetic acid (EGTA) and 10  mM imidazole, pH 6.5). For the co-phase separation of CCL5 and heparin (GlycoNovo, China, Mw: 13.980 kDa), 20 μM of CCL5 were mixed with heparin and 5% wt/vol PEG-8000 in the assay buffer. The mixtures were incubated at 37°C for 30 min then were loaded into a 96-well plate for imaging analysis. Images were captured with a Leica DMi8 confocal microscopy with a ×63 objective (oil immersion) and LAS X software 3.5.</p></sec><sec id="s4-7"><title>Turbidity assay</title><p>CCL5 proteins were mixed with various concentrations of heparin (0–1000 μM) and PEG-8000 (5% wt/vol) in the KMEI buffer. After incubation at 37°C for 30 min the mixture was transferred to a 96-well plate and turbidity was measured by absorption at 620 nm using a Multiskan FC microplate reader (Thermo Fisher, USA). All samples were examined in triplicates (<italic>n</italic> = 3).</p></sec><sec id="s4-8"><title>Molecular docking</title><p>Heparin tetrasaccharide was docked to CCL5 (PDB number: 5coy) wild-type and <sup>44</sup>AANA<sup>47</sup>-CCL5 (PDB number: 1u4r) mutation by ClusPro server (<xref ref-type="bibr" rid="bib3">Desta et al., 2020</xref>). The docked models were selected according to the following standards: (1) close to the critical residues, that is, aa 44–47 and (2) having the lowest energy score. The selected CCL5–heparin tetrasaccharide complex was handled by Glycan Reader &amp; Modeler module of CHARMM-GUI (<xref ref-type="bibr" rid="bib2">Damm et al., 1997</xref>; <xref ref-type="bibr" rid="bib13">Liu et al., 2013</xref>) to set up the molecular dynamics simulation system and generate the input files. The energy minimization (EM) simulations of the complexes were performed with GROMACS [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.softx.2015.06.001">https://doi.org/10.1016/j.softx.2015.06.001</ext-link>], and based on the EM trajectory, the binding free energy between CCL5 and heparin tetrasaccharide was calculated with gmx_MMPBSA (<xref ref-type="bibr" rid="bib33">Van Wart et al., 2014</xref>).</p></sec><sec id="s4-9"><title>Diffusion of CCL5 on heparin-beads and Ni-NTA beads</title><p>Heparin-beads (Solarbio, China) and Ni-NTA beads (GenScript, China) 50 µl gel were mixed with 400 ng/μl of His-CCL5-EGFP and <sup>44</sup>AANA<sup>47</sup>-CCL5-EGFP fusion proteins in a total volume of 500 µl. After incubation for 30 min in ice, the beads were dropped into Matrigel (ABWbionova, China) in 96-well plates kept on ice. Then the plates were moved to a 37°C incubator for 12 hr. Images were captured with a Zeiss Axiocam 506 color Fluorescence Microscope with a ×5, ×10 objective and analyzed with ImageJ.</p></sec><sec id="s4-10"><title>Chemotaxis assay</title><p>CHO-K1, mutant CHO-677, and HUVEC cells were cultured in the lower chamber of Transwell with 8 μm pores (Corning, USA) with a density 1 × 10<sup>5</sup> cells/well for 24 hr. Cells were washed three times with PBS and then 500 nM CCL5 or the mixed solution of 500 nM CCL5 and 1 mg/ml heparin (GlycoNovo, China) in culture medium were added and incubation 1 hr in a cell incubator prior to the chemotactic assay. Then the THP-1 cells (3 × 10<sup>5</sup>) in RPMI1640 medium were placed onto upper chamber of Transwell and incubated for 4 hr in a cell incubator, the transmigrated cells (in suspension) in the lower chamber were collected and counted by cell counter and inverted microscope.</p><p>For chemotaxis assay using beads, CCL5-EGFP and <sup>44</sup>AANA<sup>47</sup>-CCL5-EGFP were first mixed with the beads as described above, washed and diluted with PBS and then placed on the bottom of lower chamber. The THP-1 cells were placed in the upper chamber. Cell migration analysis was performed as described above.</p></sec><sec id="s4-11"><title>Diffusion of CCL5-EGFP on the cell surface</title><p>CCL5-EGFP was constructed in pCDNA3.1-EGFP vector (General Biosystems, China) and transiently expressed in CHO-K1 cells. Briefly, the cells were seeded on 6-well plated at a density of 2.5 × 10<sup>5</sup> cells/well in 2 ml medium for 24 hr and then transfected using Lipo8000 Transfection Reagent (Beyotime Biotechnology, China). After 12 hr; transfected cells were detached by pancreatin (2000 /ml). HUVEC cells were plated onto an 8-well Lab-Tek chambered coverglass (Thermo Fisher, USA) with a density 3 × 10<sup>4</sup> cells/well for 24 hr. The transfected CHO-K1 cells (2000/ml) in 200 µl medium were added to the 8-well coverglass coating HUVEC. After 1 hr, medium was aspirated and replaced with 50% of Matrigel. The transfected CHO-K1 was co-cultured with HUVEC cells for 12 hr, and images were captured with Leica DMi8 confocal microscopy with a ×20 objective. For the capture of droplets on cell surface and FRAP, the cellular membrane of HUVEC was stained with Dil (Cell membrane red fluorescent probe, Beyotime, China) for 20 min and washed three times with PBS. Images were captured with a ×100 objective (oil immersion).</p></sec><sec id="s4-12"><title>Human blood cells transmigration</title><p>Blood (1 ml) was collected from three healthy volunteers (we did not collect demographics) in EDTA (Ethylene Diamine Tetraacetic Acid) tubes and centrifuged at 500 × <italic>g</italic> (4°C for 5 min). After aspiration of plasma, the cells were treated with 10 ml of Red Blood Cell Lysis solution (Beyotime Biotechnology, China) for 10 min at 4°C and centrifuged. After removing supernatant, the cells were washed three times with PBS, and resuspended in 400 µl of RPMI1640 medium and counted. The cells suspension (100 µl) was added to the upper chamber for the chemotaxis assay as described above. All blood samples were obtained with informed consent, and the study was approved by the ethics review committee of China-Japan Friendship Hospital (2022-KY-050). All relevant ethical regulations of China-Japan Friendship Hospital and governmental regulations were followed.</p></sec><sec id="s4-13"><title>Recruitment of inflammatory cells in peritoneal lavage</title><p>Eight-week-old female BALB/c mice were purchased from Charles River and kept in a pathogen-free environment with fed ad lib. The procedures for care and use of animals were approved by Beijing Municipal Science &amp; Technology Commission, Administrative Commission of Zhongguancun Science Park (SYXK-2021-0056) and all applicable institutional and governmental regulations concerning the ethical use of animals were followed. Mice were injected intraperitoneally with 200 μl of NaCl (0.9%, lipopolysaccharide-free), 1 mg/ml heparin, 500 nM wild-type CCL5, 500 nM <sup>44</sup>AANA<sup>47</sup>-CCL5 or 500 nM wild-type CCL5 added by 1 mg/ml heparin diluted into 200 μl of NaCl (0.9%, lipopolysaccharide-free), respectively. At 18-hr post-injection mice were sacrificed by cervical dislocation, the cells in the peritoneal cavity were collected by lavage of 5 ml ice-cold PBS. The total cells collected were counted with automated cell counter (Bodboge, China).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Methodology</p></fn><fn fn-type="con" id="con4"><p>Methodology</p></fn><fn fn-type="con" id="con5"><p>Methodology</p></fn><fn fn-type="con" id="con6"><p>Methodology</p></fn><fn fn-type="con" id="con7"><p>Methodology</p></fn><fn fn-type="con" id="con8"><p>Methodology</p></fn><fn fn-type="con" id="con9"><p>Methodology</p></fn><fn fn-type="con" id="con10"><p>Methodology</p></fn><fn fn-type="con" id="con11"><p>Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Supervision, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All blood samples were obtained with informed consent, and the study was approved by the ethics review committee of China-Japan Friendship Hospital (2022-KY-050). All relevant ethical regulations of China-Japan Friendship Hospital and governmental regulations were followed.</p></fn><fn fn-type="other"><p>The procedures for care and use of animals were approved by Beijing Municipal Science &amp; Technology Commission, Administrative Commission of Zhongguancun Science Park (SYXK-2021-0056) and all applicable institutional and governmental regulations concerning the ethical use of animals were followed.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-93871-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files; source data files have been provided for Figures 1–6.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Shuibing Chen and Dr. Yongxiang Chen for help editing the manuscript and the support from Beijing Advanced Innovation Centre for Soft Matter Science and Engineering is acknowledged. National Key R&amp;D Program of China 2021YFC2103900 to SZL; National Natural Science Foundation of China 22261132513, 22277009, 22077010 to SZL; Joint Project of BRC-BC (Biomedical Translational Engineering Research Center of BUCT-CJFH) (XK2023-14, XK2022-07) to SZL; Swedish Research Council (2021-01094) to JPL; Postdoctoral Fellowship Program of CPSF (GZC20230211) to PFP.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandner</surname><given-names>B</given-names></name><name><surname>Rek</surname><given-names>A</given-names></name><name><surname>Diedrichs-Möhring</surname><given-names>M</given-names></name><name><surname>Wildner</surname><given-names>G</given-names></name><name><surname>Kungl</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists</article-title><source>Protein Engineering, Design &amp; Selection</source><volume>22</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1093/protein/gzp013</pub-id><pub-id pub-id-type="pmid">19414521</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damm</surname><given-names>W</given-names></name><name><surname>Frontera</surname><given-names>A</given-names></name><name><surname>Tirado–Rives</surname><given-names>J</given-names></name><name><surname>Jorgensen</surname><given-names>WL</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>OPLS all‐atom force field for carbohydrates</article-title><source>Journal of Computational Chemistry</source><volume>18</volume><fpage>1955</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199712)18:16&lt;1955::AID-JCC1&gt;3.3.CO;2-A</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desta</surname><given-names>IT</given-names></name><name><surname>Porter</surname><given-names>KA</given-names></name><name><surname>Xia</surname><given-names>B</given-names></name><name><surname>Kozakov</surname><given-names>D</given-names></name><name><surname>Vajda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Performance and its limits in rigid body protein-protein docking</article-title><source>Structure</source><volume>28</volume><fpage>1071</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1016/j.str.2020.06.006</pub-id><pub-id pub-id-type="pmid">32649857</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donlon</surname><given-names>TA</given-names></name><name><surname>Krensky</surname><given-names>AM</given-names></name><name><surname>Wallace</surname><given-names>MR</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Lovett</surname><given-names>M</given-names></name><name><surname>Clayberger</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12</article-title><source>Genomics</source><volume>6</volume><fpage>548</fpage><lpage>553</lpage></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyer</surname><given-names>DP</given-names></name><name><surname>Salanga</surname><given-names>CL</given-names></name><name><surname>Volkman</surname><given-names>BF</given-names></name><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Handel</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization</article-title><source>Glycobiology</source><volume>26</volume><fpage>312</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwv100</pub-id><pub-id pub-id-type="pmid">26582609</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Mazarakos</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>HX</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Three archetypical classes of macromolecular regulators of protein liquid-liquid phase separation</article-title><source>PNAS</source><volume>116</volume><fpage>19474</fpage><lpage>19483</lpage><pub-id pub-id-type="doi">10.1073/pnas.1907849116</pub-id><pub-id pub-id-type="pmid">31506351</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>JW</given-names></name><name><surname>Sokol</surname><given-names>CL</given-names></name><name><surname>Luster</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chemokines and chemokine receptors: positioning cells for host defense and immunity</article-title><source>Annual Review of Immunology</source><volume>32</volume><fpage>659</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120145</pub-id><pub-id pub-id-type="pmid">24655300</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoogewerf</surname><given-names>AJ</given-names></name><name><surname>Kuschert</surname><given-names>GS</given-names></name><name><surname>Proudfoot</surname><given-names>AE</given-names></name><name><surname>Borlat</surname><given-names>F</given-names></name><name><surname>Clark-Lewis</surname><given-names>I</given-names></name><name><surname>Power</surname><given-names>CA</given-names></name><name><surname>Wells</surname><given-names>TN</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Glycosaminoglycans mediate cell surface oligomerization of chemokines</article-title><source>Biochemistry</source><volume>36</volume><fpage>13570</fpage><lpage>13578</lpage><pub-id pub-id-type="doi">10.1021/bi971125s</pub-id><pub-id pub-id-type="pmid">9354625</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Yi</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Pagadala</surname><given-names>V</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zaharoff</surname><given-names>DA</given-names></name><name><surname>Pearce</surname><given-names>K</given-names></name><name><surname>Linhardt</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Construction of heparan sulfate microarray for investigating the binding of specific saccharide sequences to proteins</article-title><source>Glycobiology</source><volume>31</volume><fpage>188</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwaa068</pub-id><pub-id pub-id-type="pmid">32681173</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>AA</given-names></name><name><surname>Weber</surname><given-names>CA</given-names></name><name><surname>Jülicher</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Liquid-liquid phase separation in biology</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>30</volume><fpage>39</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013325</pub-id><pub-id pub-id-type="pmid">25288112</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kicheva</surname><given-names>A</given-names></name><name><surname>Pantazis</surname><given-names>P</given-names></name><name><surname>Bollenbach</surname><given-names>T</given-names></name><name><surname>Kalaidzidis</surname><given-names>Y</given-names></name><name><surname>Bittig</surname><given-names>T</given-names></name><name><surname>Jülicher</surname><given-names>F</given-names></name><name><surname>González-Gaitán</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Kinetics of morphogen gradient formation</article-title><source>Science</source><volume>315</volume><fpage>521</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1126/science.1135774</pub-id><pub-id pub-id-type="pmid">17255514</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>WG</given-names></name><name><surname>Triandafillou</surname><given-names>CG</given-names></name><name><surname>Huang</surname><given-names>T-Y</given-names></name><name><surname>Zulueta</surname><given-names>MML</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Dinner</surname><given-names>AR</given-names></name><name><surname>Hung</surname><given-names>S-C</given-names></name><name><surname>Tang</surname><given-names>W-J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3</article-title><source>PNAS</source><volume>113</volume><fpage>5000</fpage><lpage>5005</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523981113</pub-id><pub-id pub-id-type="pmid">27091995</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Puri</surname><given-names>A</given-names></name><name><surname>Neelamegham</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Glycosylation Network Analysis Toolbox: a MATLAB-based environment for systems glycobiology</article-title><source>Bioinformatics</source><volume>29</volume><fpage>404</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts703</pub-id><pub-id pub-id-type="pmid">23230149</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lortat-Jacob</surname><given-names>H</given-names></name><name><surname>Grosdidier</surname><given-names>A</given-names></name><name><surname>Imberty</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Structural diversity of heparan sulfate binding domains in chemokines</article-title><source>PNAS</source><volume>99</volume><fpage>1229</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1073/pnas.032497699</pub-id><pub-id pub-id-type="pmid">11830659</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makarenkova</surname><given-names>HP</given-names></name><name><surname>Hoffman</surname><given-names>MP</given-names></name><name><surname>Beenken</surname><given-names>A</given-names></name><name><surname>Eliseenkova</surname><given-names>AV</given-names></name><name><surname>Meech</surname><given-names>R</given-names></name><name><surname>Tsau</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>VN</given-names></name><name><surname>Lang</surname><given-names>RA</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis</article-title><source>Science Signaling</source><volume>2</volume><elocation-id>ra55</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2000304</pub-id><pub-id pub-id-type="pmid">19755711</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massena</surname><given-names>S</given-names></name><name><surname>Christoffersson</surname><given-names>G</given-names></name><name><surname>Hjertström</surname><given-names>E</given-names></name><name><surname>Zcharia</surname><given-names>E</given-names></name><name><surname>Vlodavsky</surname><given-names>I</given-names></name><name><surname>Ausmees</surname><given-names>N</given-names></name><name><surname>Rolny</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>JP</given-names></name><name><surname>Phillipson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils</article-title><source>Blood</source><volume>116</volume><fpage>1924</fpage><lpage>1931</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-01-266072</pub-id><pub-id pub-id-type="pmid">20530797</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulloy</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The specificity of interactions between proteins and sulfated polysaccharides</article-title><source>Anais Da Academia Brasileira de Ciencias</source><volume>77</volume><fpage>651</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1590/s0001-37652005000400007</pub-id><pub-id pub-id-type="pmid">16341442</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>KK</given-names></name><name><surname>Vibhute</surname><given-names>MA</given-names></name><name><surname>Spruijt</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Biomolecular chemistry in liquid phase separated compartments</article-title><source>Frontiers in Molecular Biosciences</source><volume>6</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2019.00021</pub-id><pub-id pub-id-type="pmid">31001538</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>K</given-names></name><name><surname>King</surname><given-names>SI</given-names></name><name><surname>McMurtry</surname><given-names>SA</given-names></name><name><surname>Schmidt</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Endothelial heparan sulfate proteoglycans in sepsis: The role of the glycocalyx</article-title><source>Seminars in Thrombosis and Hemostasis</source><volume>47</volume><fpage>274</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1055/s-0041-1725064</pub-id><pub-id pub-id-type="pmid">33794552</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Øynebråten</surname><given-names>I</given-names></name><name><surname>Barois</surname><given-names>N</given-names></name><name><surname>Bergeland</surname><given-names>T</given-names></name><name><surname>Küchler</surname><given-names>AM</given-names></name><name><surname>Bakke</surname><given-names>O</given-names></name><name><surname>Haraldsen</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>9261</elocation-id><pub-id pub-id-type="doi">10.1038/srep09261</pub-id><pub-id pub-id-type="pmid">25791723</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proudfoot</surname><given-names>AE</given-names></name><name><surname>Power</surname><given-names>CA</given-names></name><name><surname>Hoogewerf</surname><given-names>AJ</given-names></name><name><surname>Montjovent</surname><given-names>MO</given-names></name><name><surname>Borlat</surname><given-names>F</given-names></name><name><surname>Offord</surname><given-names>RE</given-names></name><name><surname>Wells</surname><given-names>TN</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>2599</fpage><lpage>2603</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.5.2599</pub-id><pub-id pub-id-type="pmid">8576227</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proudfoot</surname><given-names>AE</given-names></name><name><surname>Borlat</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Purification of recombinant chemokines from <italic>E. coli</italic></article-title><source>Methods in Molecular Biology</source><volume>138</volume><fpage>75</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1385/1-59259-058-6:75</pub-id><pub-id pub-id-type="pmid">10840744</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proudfoot</surname><given-names>AE</given-names></name><name><surname>Fritchley</surname><given-names>S</given-names></name><name><surname>Borlat</surname><given-names>F</given-names></name><name><surname>Shaw</surname><given-names>JP</given-names></name><name><surname>Vilbois</surname><given-names>F</given-names></name><name><surname>Zwahlen</surname><given-names>C</given-names></name><name><surname>Trkola</surname><given-names>A</given-names></name><name><surname>Marchant</surname><given-names>D</given-names></name><name><surname>Clapham</surname><given-names>PR</given-names></name><name><surname>Wells</surname><given-names>TN</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>10620</fpage><lpage>10626</lpage><pub-id pub-id-type="doi">10.1074/jbc.M010867200</pub-id><pub-id pub-id-type="pmid">11116158</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proudfoot</surname><given-names>AEI</given-names></name><name><surname>Handel</surname><given-names>TM</given-names></name><name><surname>Johnson</surname><given-names>Z</given-names></name><name><surname>Lau</surname><given-names>EK</given-names></name><name><surname>LiWang</surname><given-names>P</given-names></name><name><surname>Clark-Lewis</surname><given-names>I</given-names></name><name><surname>Borlat</surname><given-names>F</given-names></name><name><surname>Wells</surname><given-names>TNC</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines</article-title><source>PNAS</source><volume>100</volume><fpage>1885</fpage><lpage>1890</lpage><pub-id pub-id-type="doi">10.1073/pnas.0334864100</pub-id><pub-id pub-id-type="pmid">12571364</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proudfoot</surname><given-names>AEI</given-names></name><name><surname>Johnson</surname><given-names>Z</given-names></name><name><surname>Bonvin</surname><given-names>P</given-names></name><name><surname>Handel</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Glycosaminoglycan interactions with chemokines add complexity to a complex system</article-title><source>Pharmaceuticals</source><volume>10</volume><elocation-id>70</elocation-id><pub-id pub-id-type="doi">10.3390/ph10030070</pub-id><pub-id pub-id-type="pmid">28792472</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roscic-Mrkic</surname><given-names>B</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Leemann</surname><given-names>C</given-names></name><name><surname>Manrique</surname><given-names>A</given-names></name><name><surname>Gordon</surname><given-names>CJ</given-names></name><name><surname>Moore</surname><given-names>JP</given-names></name><name><surname>Proudfoot</surname><given-names>AEI</given-names></name><name><surname>Trkola</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement</article-title><source>Blood</source><volume>102</volume><fpage>1169</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-02-0488</pub-id><pub-id pub-id-type="pmid">12714503</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Mondal</surname><given-names>S</given-names></name><name><surname>Kordower</surname><given-names>JH</given-names></name><name><surname>Pahan</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8(+) T cells in the nigra of hemiparkinsonian monkey</article-title><source>Neuroscience</source><volume>302</volume><fpage>36</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.03.011</pub-id><pub-id pub-id-type="pmid">25783477</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salanga</surname><given-names>CL</given-names></name><name><surname>Dyer</surname><given-names>DP</given-names></name><name><surname>Kiselar</surname><given-names>JG</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Chance</surname><given-names>MR</given-names></name><name><surname>Handel</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>14896</fpage><lpage>14912</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.547737</pub-id><pub-id pub-id-type="pmid">24727473</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Needleman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Developmental biology: Rise of the source-sink model</article-title><source>Nature</source><volume>461</volume><fpage>480</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1038/461480a</pub-id><pub-id pub-id-type="pmid">19779439</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>JP</given-names></name><name><surname>Johnson</surname><given-names>Z</given-names></name><name><surname>Borlat</surname><given-names>F</given-names></name><name><surname>Zwahlen</surname><given-names>C</given-names></name><name><surname>Kungl</surname><given-names>A</given-names></name><name><surname>Roulin</surname><given-names>K</given-names></name><name><surname>Harrenga</surname><given-names>A</given-names></name><name><surname>Wells</surname><given-names>TNC</given-names></name><name><surname>Proudfoot</surname><given-names>AEI</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors</article-title><source>Structure</source><volume>12</volume><fpage>2081</fpage><lpage>2093</lpage><pub-id pub-id-type="doi">10.1016/j.str.2004.08.014</pub-id><pub-id pub-id-type="pmid">15530372</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Bu</surname><given-names>C</given-names></name><name><surname>Fraser</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Dordick</surname><given-names>JS</given-names></name><name><surname>Linhardt</surname><given-names>RJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>F</given-names></name><name><surname>Chi</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>21</volume><fpage>3608</fpage><lpage>3618</lpage><pub-id pub-id-type="doi">10.1016/j.jtha.2023.08.020</pub-id><pub-id pub-id-type="pmid">37648114</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon Davis</surname><given-names>DA</given-names></name><name><surname>Parish</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity</article-title><source>Frontiers in Immunology</source><volume>4</volume><elocation-id>470</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2013.00470</pub-id><pub-id pub-id-type="pmid">24391644</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Wart</surname><given-names>AT</given-names></name><name><surname>Durrant</surname><given-names>J</given-names></name><name><surname>Votapka</surname><given-names>L</given-names></name><name><surname>Amaro</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Weighted implementation of suboptimal paths (WISP): An optimized algorithm and tool for dynamical network analysis</article-title><source>Journal of Chemical Theory and Computation</source><volume>10</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1021/ct4008603</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>M</given-names></name><name><surname>Hauschild</surname><given-names>R</given-names></name><name><surname>Schwarz</surname><given-names>J</given-names></name><name><surname>Moussion</surname><given-names>C</given-names></name><name><surname>de Vries</surname><given-names>I</given-names></name><name><surname>Legler</surname><given-names>DF</given-names></name><name><surname>Luther</surname><given-names>SA</given-names></name><name><surname>Bollenbach</surname><given-names>T</given-names></name><name><surname>Sixt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interstitial dendritic cell guidance by haptotactic chemokine gradients</article-title><source>Science</source><volume>339</volume><fpage>328</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1126/science.1228456</pub-id><pub-id pub-id-type="pmid">23329049</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Heparan sulfate proteoglycan - A common receptor for diverse cytokines</article-title><source>Cellular Signalling</source><volume>54</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2018.11.022</pub-id><pub-id pub-id-type="pmid">30500378</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>R</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>T</given-names></name><name><surname>Luo</surname><given-names>S-Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Low-complexity domain of U1-70K modulates phase separation and aggregation through distinctive basic-acidic motifs</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaax5349</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aax5349</pub-id><pub-id pub-id-type="pmid">31723601</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J-P</given-names></name><name><surname>Luo</surname><given-names>S-Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Phase separation on cell surface facilitates bFGF signal transduction with heparan sulphate</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>1112</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28765-z</pub-id><pub-id pub-id-type="pmid">35236856</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Kambayashi</surname><given-names>Y</given-names></name><name><surname>Otsuka</surname><given-names>Y</given-names></name><name><surname>Afouda</surname><given-names>BA</given-names></name><name><surname>Giuraniuc</surname><given-names>C</given-names></name><name><surname>Michiue</surname><given-names>T</given-names></name><name><surname>Hoppler</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Positive feedback regulation of <italic>frizzled-7</italic> expression robustly shapes a steep Wnt gradient in <italic>Xenopus</italic> heart development, together with sFRP1 and heparan sulfate</article-title><source>eLife</source><volume>11</volume><elocation-id>e73818</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.73818</pub-id><pub-id pub-id-type="pmid">35942683</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>SR</given-names></name><name><surname>Burkhardt</surname><given-names>M</given-names></name><name><surname>Nowak</surname><given-names>M</given-names></name><name><surname>Ries</surname><given-names>J</given-names></name><name><surname>Petrášek</surname><given-names>Z</given-names></name><name><surname>Scholpp</surname><given-names>S</given-names></name><name><surname>Schwille</surname><given-names>P</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fgf8 morphogen gradient forms by a source-sink mechanism with freely diffusing molecules</article-title><source>Nature</source><volume>461</volume><fpage>533</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1038/nature08391</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zbinden</surname><given-names>A</given-names></name><name><surname>Pérez-Berlanga</surname><given-names>M</given-names></name><name><surname>De Rossi</surname><given-names>P</given-names></name><name><surname>Polymenidou</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phase separation and neurodegenerative diseases: A disturbance in the force</article-title><source>Developmental Cell</source><volume>55</volume><fpage>45</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.09.014</pub-id><pub-id pub-id-type="pmid">33049211</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93871.4.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Mauro Martins</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Universidade Federal de Minas Gerais</institution><country>Brazil</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Useful</kwd></kwd-group></front-stub><body><p>How the triplicate interaction between chemokines with both GAGs and G protein-coupled receptors (GPCR) works and how gradients are created and potentially maintained in vivo are poorly understood. The authors provide <bold>solid</bold> evidence to show phase separation can drive chemotactic gradient formation. The paper is a <bold>useful</bold> advance in the field of chemokine biology.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93871.4.sa1</article-id><title-group><article-title>Joint public review:</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Chemokines are known to create chemotactic gradients and it is generally recognized that in order to create these gradients they need to bind to glycosaminoglycans (GAGs) on cells and in tissues. However, how the triplicate interaction between chemokines with both GAGs and G protein-coupled receptors (GPCR) works and how gradients are created and potentially maintained in vivo is poorly understood. In their manuscript, Yu et al investigated and showed in detail the ability of soluble and cell-bound GAGs to create gradients of the chemokine CCL5. They show in vitro in a modified leukocyte migration assay that soluble GAGs and GAGs on the tumor cell line THP-1 affect leukocyte migration. This useful work contributes to our in-depth understanding of the role of GAGs in chemokine gradient creation which is important for site-directed leukocyte and potentially tumor cell migration and as such is of potential interest for scientists studying immune responses in infection, inflammation, autoimmunity and tumor biology. In their reply to the comments of both reviewers they indicate that liquid-liquid phase separation (LLPS) was not detected at lower CCL5 concentrations. This is important information since, together with the tendency of CCL5 to form oligomers, it may indicate that oligomerization is crucial for LLPS. This info should at least be added to the discussion of the manuscript.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93871.4.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Xiaolin</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Duan</surname><given-names>Guangfei</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Pei</surname><given-names>Pengfei</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Long</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Renji</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Wenrui</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hongli</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yan-Dong</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Gong</surname><given-names>Lili</given-names></name><role specific-use="author">Author</role><aff><institution>China-Japan Friendship Hospital</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lihong</given-names></name><role specific-use="author">Author</role><aff><institution>China-Japan Friendship Hospital</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Chu</surname><given-names>Ting-Ting</given-names></name><role specific-use="author">Author</role><aff><institution>Shenzhen Bay Laboratory</institution><addr-line><named-content content-type="city">Shenzhen</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jin-Ping</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Shi-Zhong</given-names></name><role specific-use="author">Author</role><aff><institution>Beijing University of Chemical Technology</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #2 (Public Review):</bold></p><p>Although the study by Xiaolin Yu et al is largely limited to in vitro data, the results of this study convincingly improve our current understanding of leukocyte migration.</p><p>(1) The conclusions of the paper are mostly supported by the data and in the revised manuscript clarification is provided concerning the exact CCL5 forms (without or with a fluorescent label or His-tag) and amounts/concentrations that were used in the individual experiments. This is important since it is known that modification of CCL5 at the N-terminus affects the interactions of CCL5 with the GPCRs CCR1, CCR3 and CCR5 and random labeling using monosuccinimidyl esters (as done by the authors with Cy-3) is targeting lysines. The revised manuscript more clearly indicates for each individual experiment which form is used. However, a discussion on the potential effects of the modifications on CCL5 in the results and discussion sections is still missing.</p></disp-quote><p>Many thanks for the reviewer's suggestion. We fully agree it is important to clarify the potential issue of Cy3 labeling, and believe it is more suitable in the Materials and Methods section (line 312-314).</p><disp-quote content-type="editor-comment"><p>(2) In general, authors used high concentrations of CCL5 in their experiments. In their reply to the comments they indicate that at lower CCL5 concentrations no LLPS is detected. This is important information since it may indicate the need for chemokine oligomerization for LLPS. This info should be added to the manuscript and comparison with for instance the obligate monomer CCL7 and another chemokine such as CXCL4 that easily forms oligomers may clarify whether LLPS is controlled by oligomerization.</p></disp-quote><p>We are pleased by the help of the reviewers and accordingly inserted a brief discussion as suggested (line 240-246).</p><disp-quote content-type="editor-comment"><p>(3) Statistical analyses have been improved in the revised manuscript.</p></disp-quote><p>Thanks to the reviewer for his/her comment.</p></body></sub-article></article>